Skip to main content

Military Health System

DOD COVID-19 vaccine roll-out continues, eye on long-term readiness

Image of Soldier getting a vaccine in his left arm. Marines with the 3rd Marine Expeditionary Brigade receive the Moderna COVID-19 vaccination shot on Camp Hansen, Okinawa, Japan on Jan. 20. Receiving the vaccine mitigates risks to military operations, allowing Marines to maintain their readiness and be able to respond to any crisis or contingency in the Indo-Pacific region. (Photo by Marine Cpl. Sarah Marshall, 3rd Marine Expeditionary Brigade.)

Recommended Content:

Coronavirus & the MHS Response | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

Moving hundreds of thousands of COVID-19 vaccines to more than 300 military bases at home and abroad is a monumental task, especially when the supply of the vaccines is still in the early stage. Perhaps more significant is the psychological impact of waiting to get a shot, understanding the facts about its safety, and wading through the daily barrage of media reports and a formidable rumor mill amid the deadliest virus to hit the United States in more than a century.

While the news has celebrated the current vaccines for being 95% or more effective to prevent illness from the virus, they remain among of the most important prevention methods to combatting the spread of COVID-19.

At a Pentagon press briefing Jan. 28, Joint Staff Surgeon Air Force Brig. Gen. Paul Friedrichs described the vaccine as a third layer of prevention against the disease, emphasizing that the shot, combined with public health measures and testing, will help control the pandemic.

He said the basic personal protection measures of physical distancing and wearing face coverings and masks are “not going to go away in the near term as we roll out the vaccines.”

That’s because research has not yet provided answers to key questions about how widely the vaccine can prevent the spread of the virus. “That’s difficult, [to know] the immediate assessment on the impact on readiness and training and operations,” said Air Force Col. (Dr.) Jessica Cowden, chief of infectious disease programs with the Defense Institute for Medical Operations, Joint Base San Antonio-Lackland in Texas.

Image of several boxes of Moderna COVID-19 vaccines
Boxes of Moderna COVID-19 vaccines are placed into a freezer at Aviano Air Base, Italy, Jan. 7, 2021. Each box holds 10 vials, with each vial containing approximately 10 doses of the vaccine. (Photo by Air Force Staff Sgt. K. Tucker Owen.)

“The phase 3 vaccine trial is designed to evaluate efficacy — how well the vaccines work to prevent clinical infection, systematic COVID. They are not designed to evaluate the vaccine’s ability to prevent an asymptomatic infection, or transmission. So those questions are still there, and still unanswered.”

Cowden, who has been on assignment with the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) and is coordinating participation in the Phase 3 COVID-19 vaccine studies, was referring to one of many challenging aspects of COVID-19 — the way in which it can easily spread from infected people who show no symptoms. It’s why even with the high efficacy of the shots, mask-wearing, physical distancing, and quarantining must continue for the foreseeable future, she stressed.

Like any medication or vaccination, it's normal to wonder about the safety of what's going into your body, and defense health experts express high levels of confidence in the safety of the COVID-19 vaccine.

“On one level, it’s amazingly fast,” said Dr. Clay Holloway, director of the Office of Strategy and Integration at JPEO CBRND, where part of the office’s charge is “medical countermeasures” for the military and special operations. “On another level, it’s unfair to say that this is all the time that’s been put into it, because we’ve spent quite a while developing the messenger RNA platform, and understanding what it can do, what it can’t do. But there are limits to how much you can profile the safety. You’ve really got to get whatever it is you’re vaccinating against, and see how that interacts with the body and whether it’s effective or not.”

In other words, the mRNA vaccine has been around for a few years now, but the COVID-19 trials are the first real test of the impact of it. The testing was unprecedented, experts agree.

“It did take the whole nationwide effort, the whole of government, the whole of industry effort to bring these forward this fast,” Holloway said, adding that “the Food and Drug Administration does its job incredibly well. When you take a drug from them ... you can be pretty confident it’s going to work.”

He added how the COVID-19 trials were accelerated by doing a lot of things in parallel instead of in a series of steps, much different from the normal method. It means looking at the same number of people tested and generating the same amount of data.

“But again, that’s not normal, because we don’t normally have the entire nation’s resources all focused on one problem,” he said. “This was unique.”

Medical personnel giving a vaccine
Navy Hospitalman Jaylen King, assigned to Navy Medicine Readiness and Training Command Corpus Christi, administers the Moderna COVID-19 vaccine to a patient at U.S. Coast Guard Sector Air Station Corpus Christi, Texas. NMRTC-CC is following the DOD’s COVID-19 vaccine distribution plan to implement a phased strategy to administer the vaccine to protect our fighting force and maintain readiness. (Photo by Dale Davis, Naval Health Clinic Corpus Christi, Texas.)

There are many other unknowns. How long can the vaccines live in the freezer? What about efficacy against new variants of the virus? When does the nation get to the point where enough people become immune to prevent the spread? Will you have immunity for life? Answers remains elusive, but waiting on every implication of a new vaccine is not what “emergency use authorization” is all about.

“We do know that it takes that second shot, or single booster [three or four weeks after the first], to get really good initial efficacy,” Cowden said. “We’ll have to see how long you keep that immunity, and that’s fairly common for different vaccines.”

With most vaccines, the idea is that you don’t get perfect protection forever, but good enough protection to keep you from becoming ill for a period, the doctors said. Take the new Shingrix vaccine, approved in 2017 to treat shingles, a painful, blistering illness. The Centers for Disease Control and Prevention recommends that healthy adults 50 and older get two doses separated by two to six months. In studies, Shingrix was more than 97% effective, and as of late 2019, protection stayed above 85% effectiveness at four years after vaccinations. Testing will continue, as with all vaccines.

Likewise, the COVID-19 vaccine needs to be tracked over time, Holloway said, to see how long the vaccinated “keep their antibodies up.” It could be that the virus needs an annual inoculation, like for seasonal influenza, but it is too early to tell. Those getting the vaccine now will not have to go back for testing, but should simply stay up to date on vaccine news to know whether they need to be re-vaccinated.

As far as the physical impact of the shots, or side effects, some people have none. Some get a sore arm. Some get headaches, or a fever. A very small number get a bad allergic reaction, but it is one that is usually seen within 15 or 20 minutes. Just like with giving blood, you are asked to stick around for a while after getting the relatively painless jab.

Despite the many articles and constant stream of information about the safety of the COVID-19 vaccines and the means of slowing the virus, the anti-vaccine sentiment remains stubborn, and is impacting efforts at effective messaging.

Recently, for example, there were many negative comments on the TRICARE Facebook page when facts on the vaccine were presented. Beneficiaries shared that they were unwilling to get a COVID-19 vaccine without knowing the long-term side effects, or that they think the vaccine is a bigger risk than COVID-19 itself (you cannot acquire COVID from the vaccines). Experts caution to be wary about unproven theories via the so-called “rumor mill,” and seek credible information.

“COVID-19 vaccines are brand new products, in a pandemic-weary world that is flooded with social media information,” said Dr. Margaret Ryan, medical director of the Defense Health Agency’s Immunization Healthcare Division. “This environment may engender much misinformation. People should be encouraged to seek reliable information from universities, the Centers for Disease Control, the FDA, and DOD — especially the DHA Immunization Healthcare Division website.”

Ryan said that though it is not mandatory for military members, she encourages everyone to be vaccinated as soon as it is offered to them.

“People should feel confident in these highly effective vaccines that have reassuring safety profiles after millions of doses have been administered,” she said. “Receiving COVID-19 vaccination reduces one’s personal risk of infection, protects other people, and helps the world to eventually emerge from the pandemic.”

You also may be interested in...

Genome Sequencing Assists Research at Naval Health Research Center

Article
1/24/2023
Lab technicians doing genome research

Learn how unique samples from naval vessels, US-Mexico border populations, and DOD beneficiaries aided in the Naval Health Research Center’s sequencing efforts.

Recommended Content:

Research & Innovation | Coronavirus & the MHS Response | Coronavirus

U.S. Military HIV Research Lends Lessons Learned to COVID-19

Article
1/19/2023
Gloved hands working in laboratory

The U.S. military has engaged in HIV research for three decades, contributing critical lessons learned, knowledge, and expertise during the COVID-19 research and vaccine development effort.

Recommended Content:

Coronavirus & the MHS Response | DOD HIV/AIDS Prevention Program | Research & Innovation | Coronavirus

Naval Medical Research Center Uses Genome Sequencing for Variants

Article
1/12/2023
Military personnel pose for a group photo

NMRC’s efforts provided important support for sequencing and viral isolation to the Department of Defense and Military Health System.

Recommended Content:

Research & Innovation | Coronavirus & the MHS Response | Coronavirus

USAMRIID Focuses on Genome Sequencing to Detect Variants

Article
1/5/2023
Military medical personnel in laboratory

A connected family of laboratories across the MHS allows a more rapid response to the outbreak.

Recommended Content:

Research & Innovation | Coronavirus & the MHS Response | Coronavirus

Whole Genome Sequencing at Tripler Army Medical Center

Article
12/29/2022
Dr. Keith Fong reviews data with other lab technicians

The third installment in a 6-part series highlighting the efforts of the Military Health System laboratories and the technicians who worked to identify COVID-19 variants using special sequencing technology.

Recommended Content:

Coronavirus & the MHS Response | Research & Innovation | Coronavirus

Walter Reed Army Institute of Research Implements SARS-CoV-2 Genome Sequencing

Article
12/23/2022
Military medical personnel in laboratory

This is the second article in a 6-part series that highlights the work of technicians and scientists in Military Health System laboratories who worked to identify COVID-19 variants using special sequencing technology.

Recommended Content:

Global Health Engagement | Coronavirus & the MHS Response | Research & Innovation

Protect Yourself With Respiratory Illnesses on the Rise

Article Around MHS
12/19/2022
Military medical personnel administering vaccine

"Tis the season, and respiratory illnesses are on the rise. Learn critical health guidance about the viral triple threat of COVID-19, influenza, and the common cold, and the commonsense steps you can take to protect yourself and your family.

Recommended Content:

Coronavirus & the MHS Response | Children's Health | Medical and Dental Preventive Care Fitness | Immunization Tool Kit | Influenza, Northern Hemisphere | Immunization Healthcare Division

Military Labs Use Whole Genome Sequencing of COVID-19 Variants

Article
12/16/2022
Lab technician at work

The first in a 6-part series highlighting the work of technicians and scientists working in support of the MHS who identified COVID-19 variants using special sequencing technology.

Recommended Content:

Research & Innovation | Coronavirus & the MHS Response | Coronavirus

DOD Reduces Health Care Waste by Reusing Crutches

Article
12/15/2022
Military personnel using crutches

When military facilities faced a national shortage of an essential mobility aid, they launched a grassroots initiative that not only ensured patient care, but also created a new waste reduction model within the DHA.

Recommended Content:

Warrior Care | Coronavirus & the MHS Response

Flu Season’s Here: You Still Can Get Your Flu Shot for Protection

Article
12/12/2022
Flu Week Infographic

It’s not too late to get vaccinated against the flu and COVID-19.

Recommended Content:

Immunization Healthcare Division | Immunization Tool Kit | Vaccine Recommendations | COVID-19 Vaccine Efforts | National Immunization Awareness Month 2022 | Immunizations | Winter Safety

MHS Minute | Nov 2022

Video
12/12/2022
MHS Minute | Nov 2022

The latest MHS Minute focuses on highlights from DHA Director Lt. Gen. Ronald J. Place’s final virtual town hall with the workforce, Nov. 16, 2022. The discussion included the agency’s biggest accomplishments over the past three years and the impact of COVID-19 on DHA’s reputation and approach to health care delivery.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus

Naval Medical Research Center Joint Study with Mount Sinai Uncovers Differences in COVID-19 Immune Response between the Sexes

Article Around MHS
12/5/2022
Amanda Cherry, research assistant, performing diagnostic testing at NMRC

A collaborative study between researchers at Naval Medical Research Center and the Icahn School of Medicine at Mount Sinai, and Princeton University has highlighted immune response differences in the coronavirus infection responses between male and female patients.

Recommended Content:

Medical Research and Development | Coronavirus & the MHS Response | Coronavirus

Get Protected With New COVID-19 Booster and Flu Vaccine

Article Around MHS
10/24/2022
Military medical personnel administering vaccine

There are two vaccines you should consider getting this Fall, and now you can get them both at the same time.

Recommended Content:

Immunizations | COVID-19 Vaccine Efforts | Seasonal Influenza Vaccine Toolkit | Coronavirus and the COVID-19 Vaccine

Collaborating In the ER: Reservists Assist, Learn in Community Hospitals

Article Around MHS
10/20/2022
Military medical personnel in medical training session

In the early days of the COVID-19 pandemic–when there were no vaccines, a shortage of health care workers, and hospitals were beyond capacity– the U.S. health care system needed help. Here's one of many ways the Department of Defense answered the call.

Recommended Content:

Coronavirus & the MHS Response

Time to Get Your Flu Shot and Your COVID-19 Booster, Too

Article
10/14/2022
Senior MHS officials and medics from the Pentagon stand together Oct. 13 after receiving their flu shots and bivalent COVID-19 boosters.."

It's flu shot time. Get your COVID-19 booster at the same time.

Recommended Content:

Coronavirus & the MHS Response | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine | Seasonal Influenza Vaccine Toolkit | Immunizations | Coronavirus
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 31
Refine your search
Last Updated: September 27, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery